<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00954200</url>
  </required_header>
  <id_info>
    <org_study_id>26.07.09.ctil</org_study_id>
    <nct_id>NCT00954200</nct_id>
  </id_info>
  <brief_title>Ibuprofen as a Possible Preventer of Post Bronchoscopy Fever</brief_title>
  <official_title>Ibuprofen as a Possible Preventer of Post Bronchoscopy Fever</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <brief_summary>
    <textblock>
      Scientific background: Bronchoscopy is a procedure commonly performed in the management of&#xD;
      persistent respiratory illness. In the last decades this exam has become a routine and safe&#xD;
      procedure even in children and there are few side-effects. However, one known side effect is&#xD;
      transient fever and even high fever a few hours after the bronchoscopy. This side effect is&#xD;
      not dangerous but very uncomfortable for the patients and it would be interesting to try to&#xD;
      reduce this phenomena. This fever is due to a release of cytokines during the&#xD;
      broncho-alveolar lavage procedure and not to sepsis. In a previous study a single dose of&#xD;
      dexamethasone was shown to prevent the fever post bronchoscopy with no apparent detriment to&#xD;
      the child. It is well known that steroids are immunosuppressive. Even though the&#xD;
      post-bronchoscopy fever is not caused by an infection, it seems preferable to use other&#xD;
      anti-inflammatory drugs to fight this very inconvenient side effect.&#xD;
&#xD;
      Ibuprofen (Nurofen*) is known as an effective medication to reduce fever in infectious&#xD;
      illnesses and is even considered as superior to paracetamol. It has no immunosuppressive&#xD;
      effect and is usually well tolerated by children with very few side effects when taken in the&#xD;
      normal therapeutic dose of 10mg/Kg. The investigators postulate that a dose of Nurofen prior&#xD;
      to bronchoscopy could significantly reduce fever post bronchoscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <completion_date type="Actual">January 2015</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Post Bronchoscopy Fever</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen</intervention_name>
    <description>ibuprofen 10mg/kg syrup, single dose vs placebo</description>
    <arm_group_label>ibuprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen</intervention_name>
    <description>10mg/kg syrup - single dose</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>ibuprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  under twelve years of age&#xD;
&#xD;
          -  all patients undergoing bronchoscopy and bronchoalveolar lavage&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  children with immune deficiency&#xD;
&#xD;
          -  allergy to NSAIDS&#xD;
&#xD;
          -  previous exacerbation of asthma due to NSAIDS&#xD;
&#xD;
          -  fever on the day of the examination&#xD;
&#xD;
          -  current antibiotic treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center POB 3235</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Picard E, Schwartz S, Goldberg S, Glick T, Villa Y, Kerem E. A prospective study of fever and bacteremia after flexible fiberoptic bronchoscopy in children. Chest. 2000 Feb;117(2):573-7.</citation>
    <PMID>10669705</PMID>
  </reference>
  <reference>
    <citation>Fonseca MT, Camargos PA, Abou Taam R, Le Bourgeois M, Scheinmann P, de Blic J. Incidence rate and factors related to post-bronchoalveolar lavage fever in children. Respiration. 2007;74(6):653-8. Epub 2007 Aug 29.</citation>
    <PMID>17728531</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>July 26, 2009</study_first_submitted>
  <study_first_submitted_qc>August 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2009</study_first_posted>
  <last_update_submitted>October 22, 2020</last_update_submitted>
  <last_update_submitted_qc>October 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2020</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

